IFN gene therapy was associated with sustained local production of IFN-β that efficiently suppressed tumor growth in prostate and bladder cancer as well as melanoma, renal cell carcinoma, and colon carcinoma (54–56). This evidence concerns the gene IFNB1 and melanoma.